Comerica Bank Xeris Biopharma Holdings, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Comerica Bank holds 611 shares of XERS stock, worth $1,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

611

Holding current value

$1,881

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$2.06 - $2.96 $1,258 - $1,808	611 New	611 $1,000
Q1 2024 May 15, 2024	BUY	$2.04 - $3.22 $850 - $1,342	417 New	417 $0

Others Institutions Holding XERS

# of Institutions

142

Shares Held

59.9M

Call Options Held

148K

Put Options Held

45.7K

Black Rock Inc. New York, NY

10.3M
Shares

$31.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.77M
Shares

$23.9 Million
0.0% of portfolio
Caxton Corp Princeton, NJ

5.11M
Shares

$15.7 Million
62.59% of portfolio
Center Book Partners LP Greenwich, CT

3.48M
Shares

$10.7 Million
0.64% of portfolio
Geode Capital Management, LLC Boston, MA

3.33M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $419M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account